SARS-CoV-2 RNA (COVID-19) and Influenza A and B, Qualitative NAAT

Test Code

31688

CPT Code(s)

87636
To meet regulatory reporting requirements for COVID-19 testing, the patient's address, phone number and other demographic details are required for this order.

CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering.

Test Code

31688

CPT Code(s)

87636
To meet regulatory reporting requirements for COVID-19 testing, the patient's address, phone number and other demographic details are required for this order.

CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering.

In-home collection is not available in your area through Quest Mobile.

Clinical Significance

SARS-CoV-2 RNA (COVID-19) and Influenza A and B, Qualitative NAAT - SARS-CoV-2 RNA (COVID-19) and Influenza A and B, Qualitative NAAT is a qualitative multi-target molecular diagnostics test that aids in simultaneous detection of COVID-19, influenza A and influenza B. This test is intended to be performed on respiratory specimens collected by a healthcare provider from individuals suspected of respiratory viral infection consistent with COVID-19 or influenza.

Result Interpretation:
• A Detected result indicates that RNA from SARS-CoV-2, influenza A, or influenza B was Detected. Clinical correlation with patient history ...

Test Resources

None found for this test
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.

Test Details

Methodology

Nucleic Acid Amplification Test (NAAT) includes RT-PCR or TMA

Assay Category

This test has been authorized by the FDA under an Emergency Use Authorization (EUA) for use by authorized laboratories.

Reference Range(s)

FLU A	Not detected
FLU B	Not detected
SARS CoV 2 RNA	Not detected

Alternative Name(s)

Novel Coronavirus,Wuhan,COVID19,Flu,nCOV,Coronavirus

LOINC® Codes, Performing Laboratory

Service Area must be determined

Methodology

Nucleic Acid Amplification Test (NAAT) includes RT-PCR or TMA

Assay Category

This test has been authorized by the FDA under an Emergency Use Authorization (EUA) for use by authorized laboratories.

Reference Range(s)

FLU A	Not detected
FLU B	Not detected
SARS CoV 2 RNA	Not detected

Alternative Name(s)

Novel Coronavirus,Wuhan,COVID19,Flu,nCOV,Coronavirus

LOINC® Codes, Performing Laboratory

Service Area must be determined

Preferred Specimen(s)

One (1) nasopharyngeal (NP) swab collected in VCM (UTM) medium tube, UTM-RT or equivalent Viral Transport Media (VTM); phosphate buffered saline (PBS) or 0.9% physiological saline
OR
One (1) nasal swab (Anterior Nares) collected in VCM (UTM) medium tube or equivalent Viral Transport Media (VTM); 0.9% physiological saline; phosphate buffered saline (PBS)

Minimum Volume

1 swab • 1 mL

Collection Instructions

Each COVID-19 specimen transport vial that is submitted should be accompanied by its own separate requisition and transported in its own sealed bag

Transport Container

Preferred sample: 3 mL VCM/UTM, UTM-RT medium or BD UVT or equivalent
OR
Plastic sterile leak-proof container

Transport Temperature

Room temperature

Specimen Stability

Room temperature: 7 days
Refrigerated: 14 days
Frozen:
Nasopharyngeal swab or Nasal (Anterior Nares) swab collected in VCM (UTM) medium tube, UTM-RT or equivalent Viral Transport media (VTM): 30 days
Nasal (Anterior Nares) swab collected in 0.9% physiological saline: 7 days
Nasopharyngeal swab or Nasal (Anterior Nares) swab collected in phosphate buffered saline (PBS): Unacceptable

Reject Criteria

Calcium alginate swabs • Cotton swabs with wooden shaft • Amies liquid or gel transport used for bacterial cultures

Setup Schedule

Service Area must be determined

Preferred Specimen(s)

Minimum Volume

1 swab • 1 mL

Collection Instructions

Each COVID-19 specimen transport vial that is submitted should be accompanied by its own separate requisition and transported in its own sealed bag

Transport Container

Preferred sample: 3 mL VCM/UTM, UTM-RT medium or BD UVT or equivalent
OR
Plastic sterile leak-proof container

Transport Temperature

Room temperature

Specimen Stability

Room temperature: 7 days
Refrigerated: 14 days
Frozen:
Nasopharyngeal swab or Nasal (Anterior Nares) swab collected in VCM (UTM) medium tube, UTM-RT or equivalent Viral Transport media (VTM): 30 days

Nasal (Anterior Nares) swab collected in 0.9% physiological saline: 7 days

Nasopharyngeal swab or Nasal (Anterior Nares) swab collected in phosphate buffered saline (PBS): Unacceptable

Reject Criteria

Calcium alginate swabs • Cotton swabs with wooden shaft • Amies liquid or gel transport used for bacterial cultures

Setup Schedule

Service Area must be determined

In-home collection is not available in your area through Quest Mobile.

Test Details

Clinical Significance

Test Resources

Reference ranges are provided as general guidance only. To interpret test results use the reference range in the laboratory report.

The CPT codes provided are based on AMA guidance and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

This material contains content from LOINC® (http://loinc.org). The LOINC Table, LOINC Table Core are copyright © 1995-2019, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license.

The tests listed by specialty and category are a select group of tests offered. For a complete list of Quest Diagnostics tests, please adjust the filter options chosen, or refer to our Directory of Services.